| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Leucovorin | FAERS: 2 | US FAERS | |
| 2 | NuvaRing | FAERS: 2 | US FAERS | |
| 3 | Dasatinib | FAERS: 1 | US FAERS | |
| 4 | LCZ 696 | FAERS: 1 | US FAERS | |
| 5 | Methotrexate | FAERS: 1 | US FAERS | |
| 6 | Pemetrexed | FAERS: 1 | US FAERS | |
| 7 | Raloxifene Hydrochloride | FAERS: 1 | US FAERS | |
| 8 | Rosiglitazone | FAERS: 1 | US FAERS | |
| 9 | Ruxolitinib phosphate | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 10 | Thiotepa | FAERS: 1 | US FAERS | |
| 11 | pazopanib | FAERS: 1 | US FAERS | |
| 12 | Cytarabine | OFFSIDES | ||
| 13 | Lamotrigine | OFFSIDES | ||
| 14 | Leucovorin | OFFSIDES | ||
| 15 | Methotrexate | Canada Vigilance: 1 | Canada Vigilance |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120326
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.